Patents by Inventor Edward M. Lichten

Edward M. Lichten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210308147
    Abstract: By initially lowering the SHBG with a synthetic androgen and, thereafter, raising the testosterone level in a person's body, an effective method for treating a corona virus is achieved by first using a synthetic anabolic steroid and, thereafter, a natural androgen.
    Type: Application
    Filed: June 2, 2021
    Publication date: October 7, 2021
    Inventor: Edward M. Lichten
  • Publication number: 20210038617
    Abstract: By initially lowering the SHBG with a synthetic androgen and, thereafter, raising the testosterone level in a person's body, an effective method for treating an identified disease selected from the group consisting of hereditary angioedema, lupus erythematosus, auto immune diseases, connective tissue diseases is achieved by first administering a synthetic anabolic steroid and, thereafter, a natural androgen.
    Type: Application
    Filed: October 22, 2020
    Publication date: February 11, 2021
    Inventor: Edward M. Lichten
  • Publication number: 20200376001
    Abstract: By initially lowering the SHBG with a synthetic androgen and, thereafter, raising the testosterone level in a person's body, an effective method for treating gastrointestinal disorders such as irritable bowel syndrome, inflammatory bowel diseases, including Crohn's Disease and ulcerative colitis, is achieved by first using a synthetic anabolic steroid and, thereafter, a natural androgen.
    Type: Application
    Filed: August 19, 2020
    Publication date: December 3, 2020
    Inventor: Edward M. Lichten
  • Publication number: 20200237855
    Abstract: A method of treating PTSD combines oxytocin with an additional neurotransmitter and, optionally, a minor amount of an amino acid amastatin. The composition may be deployed as either a lozenge or as a topical cream. Also, an effective legal quantity of CBD oil may be used conjointly therewith, whether directly incorporated in the composition or used separately.
    Type: Application
    Filed: January 30, 2020
    Publication date: July 30, 2020
    Inventor: Edward M. Lichten
  • Publication number: 20170266205
    Abstract: A topical cream applied to a nipple of a lactating female induces lactation. The cream comprises a base cream having from about 0.5% to about 10%, by volume, of a steroid, based upon the total volume of the cream. The preferred steroid is stanozolol. Preferably, the cream comprises at least about 1% to about 10%, by volume, of stanozolol, based on the total volume of the cream.
    Type: Application
    Filed: April 4, 2017
    Publication date: September 21, 2017
    Inventor: Edward M. Lichten
  • Publication number: 20170246192
    Abstract: By lowering the amount of Sexual Hormone Binding Globulin (SHBG) and, thereafter, raising the serum testosterone level in a person's body, an effective method for treating gastrointestinal disorders such as irritable bowel syndrome and inflammatory bowel disease, including Crohn's Disease and ulcerative colitis, is achieved. First and second androgens, namely, anabolic steroids, are used to lower the SHBG and, thereafter, raise the serum testosterone level in the body, respectively. The SHBG is lowered and the testosterone level is increased until an equilibrium between the SHBG and the second androgen is reached which normalizes the Free Androgen Index (FAI) in the person's body. Preferably, the first androgen used herein to lower the SHBG is stanozolol and the second androgen used herein to normalize the FAI is testosterone.
    Type: Application
    Filed: March 13, 2017
    Publication date: August 31, 2017
    Inventor: Edward M. Lichten
  • Patent number: 9610296
    Abstract: A topical cream applied to a nipple of a lactating female induces lactation. The cream comprises a base cream having from about 0.5% to about 10%, by volume, of a steroid, based upon the total volume of the cream. The preferred steroid is stanozolol. Preferably, the cream comprises at least about 1% to about 10%, by volume, of stanozolol, based on the total volume of the cream.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: April 4, 2017
    Inventor: Edward M. Lichten
  • Publication number: 20150216880
    Abstract: A topical cream applied to a nipple of a lactating female induces lactation. The cream comprises a base cream having from about 0.5% to about 10%, by volume, of a steroid, based upon the total volume of the cream. The preferred steroid is stanozolol. Preferably, the cream comprises at least about 1% to about 10%, by volume, of stanozolol, based on the total volume of the cream.
    Type: Application
    Filed: February 4, 2015
    Publication date: August 6, 2015
    Inventor: Edward M. Lichten
  • Patent number: 8835406
    Abstract: A method of treating a patient inflicted with Reynaud's Disease including the step of injecting into the back of the patient's hand an effective amount of a hyaluronic product, thereby creating a glove-like insulation to decrease the blood vessel vasospasm.
    Type: Grant
    Filed: January 18, 2013
    Date of Patent: September 16, 2014
    Inventor: Edward M. Lichten
  • Publication number: 20140088050
    Abstract: By lowering and then after raising the amount of SHBG in the body, an effective method for treatment of various diseases is achieved. First and seconds androgens, namely, anabolic steroids are used to both lower the SHBG and, thereafter raise the testosterone in the body until equilibrium between the SHBG and the second steroid, to normalize the FAI. Stanozolol is the preferred anabolic steroid used herein to lower the SHBG and testosterone is used to normalize the FAI.
    Type: Application
    Filed: September 24, 2013
    Publication date: March 27, 2014
    Inventor: Edward M. Lichten
  • Publication number: 20140045804
    Abstract: A topical cream to be applied to the clitoris and hood of the vaginal area to create an intense libido and drive for orgasm. The cream comprises a base cream having from about 9.5% to about 10%, by volume, of a steroid, based upon the total volume of the cream. Preferably, at least about 1% to about 10% by volume, of the steroid, based on the total volume of the cream. The topical cream may, also, include from about 0.1% to about 2.0%, by volume, of oxytocin. The addition of the small amount thereof enhances the efficacy of the cream.
    Type: Application
    Filed: January 21, 2013
    Publication date: February 13, 2014
    Inventor: Edward M. Lichten
  • Publication number: 20140031311
    Abstract: A method of treating a patient inflicted with Reynaud's Disease including the step of injecting into the back of the patient's hand an effective amount of a hyaluronic product, thereby creating a glove-like insulation to decrease the blood vessel vasospasm.
    Type: Application
    Filed: January 18, 2013
    Publication date: January 30, 2014
    Inventor: Edward M. Lichten
  • Patent number: 6488649
    Abstract: Disclosed is an implant device adapted to implant medicaments into the subcutaneous portion of the patient's tissue comprising a housing having a central chamber generally in which a pusher assembly maneuvers.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: December 3, 2002
    Inventor: Edward M. Lichten
  • Publication number: 20020061869
    Abstract: The present invention is directed to a method of identifying a mammal with a hormone disorder, or identifying a mammal at risk of developing a hormone disorder. The method comprises determining the serum concentration of estrogen, testosterone, sex hormone-binding globulin, and insulin in the mammal, calculating their ratio, or F factor, and administering to the mammal a hormone disorder-effective amount of a therapeutic agent until a therapeutic F factor is achieved, or maintained in the mammal. The present invention is also directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a hormone disorder, or a disease or disorder associated with, or related to, a hormone disorder, such as cardiovascular disease.
    Type: Application
    Filed: July 2, 2001
    Publication date: May 23, 2002
    Inventor: Edward M. Lichten